Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)

Decrease in circulating iNKT cell activation during regadenoson (RA) infusion into patients with COVID-19. by Joseph Rabin (7399436)

Subjects:

This is the raw data of Immunofluorescence in Met-5A cell. by Yangyang Yin (14323701)

Subjects:

This is the raw data of Western blot in Met-5A cell. by Yangyang Yin (14323701)

Subjects:

MiR-132-3p was downregulated in TGF-<i>β</i>1 stimulated Met-5A cells and miR-132-3p mimics and miR-132-3p inhibitor transfected Met-5A cells. by Yangyang Yin (14323701)

Subjects:

This is the raw data of IHC-2 、qPCR、Masson and HE in Rat、qPCR in human peritoneal solution and qPCR in Met-5A cell. by Yangyang Yin (14323701)

Subjects:

Demonstration of decreased Aβ accumulation by DA-9601 treatment. by Mijung Lee (397790)

Overexpression of miR-132-3p inhibits the TGF-<i>β</i>1/Smad2/3 signaling pathway in TGF-<i>β</i>1 induced MET-5A cells. by Yangyang Yin (14323701)

Subjects:

Changes of fibrotic proteins in rat peritoneum. by Yangyang Yin (14323701)

Subjects:

Changes of miR-132-3p in peritoneal dialysis patients with different duration. by Yangyang Yin (14323701)

Subjects:

This is the raw data of IHC-1 in Rat. by Yangyang Yin (14323701)

Subjects:

Regulation of TGF-<i>β</i>1 protein expression by MiR-132-3p was verified using WB. by Yangyang Yin (14323701)

Subjects:

The effect of MiR-132-3p on protein expression in TGF-<i>β</i>1/Smad2/3 signaling pathway was observed by immunofluorescence. by Yangyang Yin (14323701)

Subjects:

Sequences of the primers for q-PCR. by Yangyang Yin (14323701)

Subjects:

Changes of peritoneal structure and function in rats. by Yangyang Yin (14323701)

Subjects:

Changes of miR-132-3p in rat peritoneum. by Yangyang Yin (14323701)

Subjects:

Diabetic wounds show increased amounts of vessel leakage and decreased pericyte coverage. by Uzoagu A. Okonkwo (8754933)

rhMG53 decreases membrane damage <i>in vitro</i>. by Brian J. Paleo (8694246)

Weighted odds ratios reflecting the impact of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints. by Aeron M. Small (9617751)

“…<p>Odds ratio and 95% confidence interval is displayed for the effect of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints for White individuals, Black individuals, Hispanic individuals, and inverse variance weighted meta-analysis of White, Black, and Hispanic populations (IVWMA). …”

SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

“…<p>Odds ratios (OR) and 95% confidence intervals of SLE and MS cohorts. For all graphs, the dotted line represents an OR of 1.0. …”